Negocios · 16/10/20091 min de lectura
National Mammography Quality Assurance Advisory Committee; Notice of Postponement of Meeting
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is postponing the meeting of the National Mammography Quality Assurance Advisory Committee scheduled for November 2, 2009. This meeting was announced in the Federal Register of October 1, 2009 (74 FR 50803). The postponement is due to guidance documents planned for discussion at the meeting are not yet available. A future meeting date will be announced in the Federal Register.